BAY 58-2667, an NO-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts

समान संसाधन

• Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro
  द्वारा: Ritchie, Rebecca, और अन्य
  प्रकाशित: (2009)
• The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
  द्वारा: Irvine, Jennifer C., और अन्य
  प्रकाशित: (2012)
• Structure of Cinaciguat (BAY 58–2667) Bound to Nostoc H-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase
  द्वारा: Martin, Faye, और अन्य
  प्रकाशित: (2010)
• Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
  द्वारा: Radovits, Tamás, और अन्य
  प्रकाशित: (2009)
• Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
  द्वारा: Frey, Reiner, और अन्य
  प्रकाशित: (2011)